SciSparc (SPRC) has a profit margin of -8.54%, below the Healthcare sector average of 15.52%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
The latest profit margin for SPRC is -8.54% as of December 2025. That compares with -1.83% in the prior-year period — down 367.8% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside SciSparc's historical trend and sector peers before judging valuation or financial health.
Over the past year, SPRC's profit margin moved from -1.83% to -8.54% — a 367.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in SciSparc's valuation or profitability profile.
Against Healthcare companies, SPRC currently prints -8.54% for profit margin, while the sector average sits near 15.52%. That is roughly 5602.4% below the sector mean. Large gaps often invite a closer look at SciSparc's growth, margins, and balance sheet.
Profit Margin shows how effectively SciSparc converts resources into returns. At -8.54%, SPRC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.83% in the prior-year period — down 367.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SPRC's profit margin (-8.54%), review year-over-year change from -1.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.